ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Immune Drugs Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-39Q13981
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Immune Drugs Market Research Report 2023
BUY CHAPTERS

Global Immune Drugs Market Research Report 2025

Code: QYRE-Auto-39Q13981
Report
May 2025
Pages:106
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Takeda
3S Bio
Bristol-Myers Squibb(BMS)
Eli Lilly
Mitsubishi Tanabe Pharma
Biogen
Pfizer Inc
Sanofi
Roche
Novartis
Johnson & Johnson (J&J)
Amgen Inc
Abbvi
Horizo​​n Therapeutics
Antares Pharma, Inc.
Astellas
GSK
Incyte
UCB

Immune Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Immune Drugs Market

Immune Drugs Market

The global market for Immune Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Immune Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immune Drugs.
The Immune Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Immune Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immune Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Immune Drugs Market Report

Report Metric Details
Report Name Immune Drugs Market
CAGR 5%
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Antares Pharma, Inc., UCB, Incyte, GSK, Takeda, 3S Bio, Horizo​​n Therapeutics, Bristol-Myers Squibb (BMS, Astellas, Eli Lilly, Mitsubishi Tanabe Pharma, Biogen, Pfizer, Sanofi, Roche, Novartis, Johnson & Johnson (J&J), Amgen, Abbvi
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Immune Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Immune Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Immune Drugs Market report?

Ans: The main players in the Immune Drugs Market are Antares Pharma, Inc., UCB, Incyte, GSK, Takeda, 3S Bio, Horizo​​n Therapeutics, Bristol-Myers Squibb (BMS, Astellas, Eli Lilly, Mitsubishi Tanabe Pharma, Biogen, Pfizer, Sanofi, Roche, Novartis, Johnson & Johnson (J&J), Amgen, Abbvi

What are the Application segmentation covered in the Immune Drugs Market report?

Ans: The Applications covered in the Immune Drugs Market report are Hospital, Clinic, Surgery Center, Others

What are the Type segmentation covered in the Immune Drugs Market report?

Ans: The Types covered in the Immune Drugs Market report are Immune Boosting Drugs, Immunosuppressant Drugs

Recommended Reports

Immunotherapy & Anti-Infectives

Pharma Manufacturing & Testing

Allergy & Drug Diagnostics

1 Immune Drugs Market Overview
1.1 Product Definition
1.2 Immune Drugs by Type
1.2.1 Global Immune Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Immune Boosting Drugs
1.2.3 Immunosuppressant Drugs
1.3 Immune Drugs by Application
1.3.1 Global Immune Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Surgery Center
1.3.5 Others
1.4 Global Immune Drugs Market Size Estimates and Forecasts
1.4.1 Global Immune Drugs Revenue 2020-2031
1.4.2 Global Immune Drugs Sales 2020-2031
1.4.3 Global Immune Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Immune Drugs Market Competition by Manufacturers
2.1 Global Immune Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Immune Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Immune Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Immune Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Immune Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Immune Drugs, Product Type & Application
2.7 Global Key Manufacturers of Immune Drugs, Date of Enter into This Industry
2.8 Global Immune Drugs Market Competitive Situation and Trends
2.8.1 Global Immune Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Immune Drugs Players Market Share by Revenue
2.8.3 Global Immune Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Immune Drugs Market Scenario by Region
3.1 Global Immune Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Immune Drugs Sales by Region: 2020-2031
3.2.1 Global Immune Drugs Sales by Region: 2020-2025
3.2.2 Global Immune Drugs Sales by Region: 2026-2031
3.3 Global Immune Drugs Revenue by Region: 2020-2031
3.3.1 Global Immune Drugs Revenue by Region: 2020-2025
3.3.2 Global Immune Drugs Revenue by Region: 2026-2031
3.4 North America Immune Drugs Market Facts & Figures by Country
3.4.1 North America Immune Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Immune Drugs Sales by Country (2020-2031)
3.4.3 North America Immune Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Immune Drugs Market Facts & Figures by Country
3.5.1 Europe Immune Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Immune Drugs Sales by Country (2020-2031)
3.5.3 Europe Immune Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Immune Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Immune Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Immune Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Immune Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Immune Drugs Market Facts & Figures by Country
3.7.1 Latin America Immune Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Immune Drugs Sales by Country (2020-2031)
3.7.3 Latin America Immune Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Immune Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Immune Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Immune Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Immune Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Immune Drugs Sales by Type (2020-2031)
4.1.1 Global Immune Drugs Sales by Type (2020-2025)
4.1.2 Global Immune Drugs Sales by Type (2026-2031)
4.1.3 Global Immune Drugs Sales Market Share by Type (2020-2031)
4.2 Global Immune Drugs Revenue by Type (2020-2031)
4.2.1 Global Immune Drugs Revenue by Type (2020-2025)
4.2.2 Global Immune Drugs Revenue by Type (2026-2031)
4.2.3 Global Immune Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Immune Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Immune Drugs Sales by Application (2020-2031)
5.1.1 Global Immune Drugs Sales by Application (2020-2025)
5.1.2 Global Immune Drugs Sales by Application (2026-2031)
5.1.3 Global Immune Drugs Sales Market Share by Application (2020-2031)
5.2 Global Immune Drugs Revenue by Application (2020-2031)
5.2.1 Global Immune Drugs Revenue by Application (2020-2025)
5.2.2 Global Immune Drugs Revenue by Application (2026-2031)
5.2.3 Global Immune Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Immune Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Antares Pharma, Inc.
6.1.1 Antares Pharma, Inc. Company Information
6.1.2 Antares Pharma, Inc. Description and Business Overview
6.1.3 Antares Pharma, Inc. Immune Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Antares Pharma, Inc. Immune Drugs Product Portfolio
6.1.5 Antares Pharma, Inc. Recent Developments/Updates
6.2 UCB
6.2.1 UCB Company Information
6.2.2 UCB Description and Business Overview
6.2.3 UCB Immune Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 UCB Immune Drugs Product Portfolio
6.2.5 UCB Recent Developments/Updates
6.3 Incyte
6.3.1 Incyte Company Information
6.3.2 Incyte Description and Business Overview
6.3.3 Incyte Immune Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Incyte Immune Drugs Product Portfolio
6.3.5 Incyte Recent Developments/Updates
6.4 GSK
6.4.1 GSK Company Information
6.4.2 GSK Description and Business Overview
6.4.3 GSK Immune Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 GSK Immune Drugs Product Portfolio
6.4.5 GSK Recent Developments/Updates
6.5 Takeda
6.5.1 Takeda Company Information
6.5.2 Takeda Description and Business Overview
6.5.3 Takeda Immune Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Takeda Immune Drugs Product Portfolio
6.5.5 Takeda Recent Developments/Updates
6.6 3S Bio
6.6.1 3S Bio Company Information
6.6.2 3S Bio Description and Business Overview
6.6.3 3S Bio Immune Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 3S Bio Immune Drugs Product Portfolio
6.6.5 3S Bio Recent Developments/Updates
6.7 Horizo​​n Therapeutics
6.7.1 Horizo​​n Therapeutics Company Information
6.7.2 Horizo​​n Therapeutics Description and Business Overview
6.7.3 Horizo​​n Therapeutics Immune Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Horizo​​n Therapeutics Immune Drugs Product Portfolio
6.7.5 Horizo​​n Therapeutics Recent Developments/Updates
6.8 Bristol-Myers Squibb (BMS
6.8.1 Bristol-Myers Squibb (BMS Company Information
6.8.2 Bristol-Myers Squibb (BMS Description and Business Overview
6.8.3 Bristol-Myers Squibb (BMS Immune Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bristol-Myers Squibb (BMS Immune Drugs Product Portfolio
6.8.5 Bristol-Myers Squibb (BMS Recent Developments/Updates
6.9 Astellas
6.9.1 Astellas Company Information
6.9.2 Astellas Description and Business Overview
6.9.3 Astellas Immune Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Astellas Immune Drugs Product Portfolio
6.9.5 Astellas Recent Developments/Updates
6.10 Eli Lilly
6.10.1 Eli Lilly Company Information
6.10.2 Eli Lilly Description and Business Overview
6.10.3 Eli Lilly Immune Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Eli Lilly Immune Drugs Product Portfolio
6.10.5 Eli Lilly Recent Developments/Updates
6.11 Mitsubishi Tanabe Pharma
6.11.1 Mitsubishi Tanabe Pharma Company Information
6.11.2 Mitsubishi Tanabe Pharma Description and Business Overview
6.11.3 Mitsubishi Tanabe Pharma Immune Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Mitsubishi Tanabe Pharma Immune Drugs Product Portfolio
6.11.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.12 Biogen
6.12.1 Biogen Company Information
6.12.2 Biogen Description and Business Overview
6.12.3 Biogen Immune Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Biogen Immune Drugs Product Portfolio
6.12.5 Biogen Recent Developments/Updates
6.13 Pfizer
6.13.1 Pfizer Company Information
6.13.2 Pfizer Description and Business Overview
6.13.3 Pfizer Immune Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Pfizer Immune Drugs Product Portfolio
6.13.5 Pfizer Recent Developments/Updates
6.14 Sanofi
6.14.1 Sanofi Company Information
6.14.2 Sanofi Description and Business Overview
6.14.3 Sanofi Immune Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Sanofi Immune Drugs Product Portfolio
6.14.5 Sanofi Recent Developments/Updates
6.15 Roche
6.15.1 Roche Company Information
6.15.2 Roche Description and Business Overview
6.15.3 Roche Immune Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Roche Immune Drugs Product Portfolio
6.15.5 Roche Recent Developments/Updates
6.16 Novartis
6.16.1 Novartis Company Information
6.16.2 Novartis Description and Business Overview
6.16.3 Novartis Immune Drugs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Novartis Immune Drugs Product Portfolio
6.16.5 Novartis Recent Developments/Updates
6.17 Johnson & Johnson (J&J)
6.17.1 Johnson & Johnson (J&J) Company Information
6.17.2 Johnson & Johnson (J&J) Description and Business Overview
6.17.3 Johnson & Johnson (J&J) Immune Drugs Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Johnson & Johnson (J&J) Immune Drugs Product Portfolio
6.17.5 Johnson & Johnson (J&J) Recent Developments/Updates
6.18 Amgen
6.18.1 Amgen Company Information
6.18.2 Amgen Description and Business Overview
6.18.3 Amgen Immune Drugs Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Amgen Immune Drugs Product Portfolio
6.18.5 Amgen Recent Developments/Updates
6.19 Abbvi
6.19.1 Abbvi Company Information
6.19.2 Abbvi Description and Business Overview
6.19.3 Abbvi Immune Drugs Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Abbvi Immune Drugs Product Portfolio
6.19.5 Abbvi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Immune Drugs Industry Chain Analysis
7.2 Immune Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Immune Drugs Production Mode & Process Analysis
7.4 Immune Drugs Sales and Marketing
7.4.1 Immune Drugs Sales Channels
7.4.2 Immune Drugs Distributors
7.5 Immune Drugs Customer Analysis
8 Immune Drugs Market Dynamics
8.1 Immune Drugs Industry Trends
8.2 Immune Drugs Market Drivers
8.3 Immune Drugs Market Challenges
8.4 Immune Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Takeda
3S Bio
Bristol-Myers Squibb(BMS)
Eli Lilly
Mitsubishi Tanabe Pharma
Biogen
Pfizer Inc
Sanofi
Roche
Novartis
Johnson & Johnson (J&J)
Amgen Inc
Abbvi
Horizo​​n Therapeutics
Antares Pharma, Inc.
Astellas
GSK
Incyte
UCB
List of Tables
 Table 1. Global Immune Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Immune Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Immune Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Immune Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Immune Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Immune Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Immune Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Immune Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Immune Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Immune Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Immune Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Immune Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Immune Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Immune Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Immune Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global Immune Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Immune Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global Immune Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Immune Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Immune Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Immune Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Immune Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Immune Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Immune Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America Immune Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America Immune Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Immune Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Immune Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Immune Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Immune Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Immune Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Immune Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Immune Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Immune Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Immune Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Immune Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Immune Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Immune Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Immune Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Immune Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Immune Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Immune Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Immune Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Immune Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Immune Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Immune Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Immune Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Immune Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global Immune Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global Immune Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Immune Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Immune Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Immune Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Immune Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Immune Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Immune Drugs Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Immune Drugs Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Immune Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global Immune Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global Immune Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Immune Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Immune Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Immune Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Immune Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Immune Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Immune Drugs Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Immune Drugs Price (US$/Unit) by Application (2026-2031)
 Table 70. Antares Pharma, Inc. Company Information
 Table 71. Antares Pharma, Inc. Description and Business Overview
 Table 72. Antares Pharma, Inc. Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Antares Pharma, Inc. Immune Drugs Product
 Table 74. Antares Pharma, Inc. Recent Developments/Updates
 Table 75. UCB Company Information
 Table 76. UCB Description and Business Overview
 Table 77. UCB Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. UCB Immune Drugs Product
 Table 79. UCB Recent Developments/Updates
 Table 80. Incyte Company Information
 Table 81. Incyte Description and Business Overview
 Table 82. Incyte Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Incyte Immune Drugs Product
 Table 84. Incyte Recent Developments/Updates
 Table 85. GSK Company Information
 Table 86. GSK Description and Business Overview
 Table 87. GSK Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. GSK Immune Drugs Product
 Table 89. GSK Recent Developments/Updates
 Table 90. Takeda Company Information
 Table 91. Takeda Description and Business Overview
 Table 92. Takeda Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Takeda Immune Drugs Product
 Table 94. Takeda Recent Developments/Updates
 Table 95. 3S Bio Company Information
 Table 96. 3S Bio Description and Business Overview
 Table 97. 3S Bio Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. 3S Bio Immune Drugs Product
 Table 99. 3S Bio Recent Developments/Updates
 Table 100. Horizo​​n Therapeutics Company Information
 Table 101. Horizo​​n Therapeutics Description and Business Overview
 Table 102. Horizo​​n Therapeutics Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Horizo​​n Therapeutics Immune Drugs Product
 Table 104. Horizo​​n Therapeutics Recent Developments/Updates
 Table 105. Bristol-Myers Squibb (BMS Company Information
 Table 106. Bristol-Myers Squibb (BMS Description and Business Overview
 Table 107. Bristol-Myers Squibb (BMS Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Bristol-Myers Squibb (BMS Immune Drugs Product
 Table 109. Bristol-Myers Squibb (BMS Recent Developments/Updates
 Table 110. Astellas Company Information
 Table 111. Astellas Description and Business Overview
 Table 112. Astellas Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Astellas Immune Drugs Product
 Table 114. Astellas Recent Developments/Updates
 Table 115. Eli Lilly Company Information
 Table 116. Eli Lilly Description and Business Overview
 Table 117. Eli Lilly Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Eli Lilly Immune Drugs Product
 Table 119. Eli Lilly Recent Developments/Updates
 Table 120. Mitsubishi Tanabe Pharma Company Information
 Table 121. Mitsubishi Tanabe Pharma Description and Business Overview
 Table 122. Mitsubishi Tanabe Pharma Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Mitsubishi Tanabe Pharma Immune Drugs Product
 Table 124. Mitsubishi Tanabe Pharma Recent Developments/Updates
 Table 125. Biogen Company Information
 Table 126. Biogen Description and Business Overview
 Table 127. Biogen Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Biogen Immune Drugs Product
 Table 129. Biogen Recent Developments/Updates
 Table 130. Pfizer Company Information
 Table 131. Pfizer Description and Business Overview
 Table 132. Pfizer Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Pfizer Immune Drugs Product
 Table 134. Pfizer Recent Developments/Updates
 Table 135. Sanofi Company Information
 Table 136. Sanofi Description and Business Overview
 Table 137. Sanofi Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Sanofi Immune Drugs Product
 Table 139. Sanofi Recent Developments/Updates
 Table 140. Roche Company Information
 Table 141. Roche Description and Business Overview
 Table 142. Roche Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Roche Immune Drugs Product
 Table 144. Roche Recent Developments/Updates
 Table 145. Novartis Company Information
 Table 146. Novartis Description and Business Overview
 Table 147. Novartis Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Novartis Immune Drugs Product
 Table 149. Novartis Recent Developments/Updates
 Table 150. Johnson & Johnson (J&J) Company Information
 Table 151. Johnson & Johnson (J&J) Description and Business Overview
 Table 152. Johnson & Johnson (J&J) Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Johnson & Johnson (J&J) Immune Drugs Product
 Table 154. Johnson & Johnson (J&J) Recent Developments/Updates
 Table 155. Amgen Company Information
 Table 156. Amgen Description and Business Overview
 Table 157. Amgen Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Amgen Immune Drugs Product
 Table 159. Amgen Recent Developments/Updates
 Table 160. Abbvi Company Information
 Table 161. Abbvi Description and Business Overview
 Table 162. Abbvi Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Abbvi Immune Drugs Product
 Table 164. Abbvi Recent Developments/Updates
 Table 165. Key Raw Materials Lists
 Table 166. Raw Materials Key Suppliers Lists
 Table 167. Immune Drugs Distributors List
 Table 168. Immune Drugs Customers List
 Table 169. Immune Drugs Market Trends
 Table 170. Immune Drugs Market Drivers
 Table 171. Immune Drugs Market Challenges
 Table 172. Immune Drugs Market Restraints
 Table 173. Research Programs/Design for This Report
 Table 174. Key Data Information from Secondary Sources
 Table 175. Key Data Information from Primary Sources
 Table 176. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Immune Drugs
 Figure 2. Global Immune Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Immune Drugs Market Share by Type: 2024 & 2031
 Figure 4. Immune Boosting Drugs Product Picture
 Figure 5. Immunosuppressant Drugs Product Picture
 Figure 6. Global Immune Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Immune Drugs Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Surgery Center
 Figure 11. Others
 Figure 12. Global Immune Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Immune Drugs Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Immune Drugs Sales (2020-2031) & (K Units)
 Figure 15. Global Immune Drugs Average Price (US$/Unit) & (2020-2031)
 Figure 16. Immune Drugs Report Years Considered
 Figure 17. Immune Drugs Sales Share by Manufacturers in 2024
 Figure 18. Global Immune Drugs Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Immune Drugs Players: Market Share by Revenue in Immune Drugs in 2024
 Figure 20. Immune Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Immune Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Immune Drugs Sales Market Share by Country (2020-2031)
 Figure 23. North America Immune Drugs Revenue Market Share by Country (2020-2031)
 Figure 24. United States Immune Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Immune Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Immune Drugs Sales Market Share by Country (2020-2031)
 Figure 27. Europe Immune Drugs Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Immune Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Immune Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Immune Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Immune Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Immune Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Immune Drugs Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Immune Drugs Revenue Market Share by Region (2020-2031)
 Figure 35. China Immune Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Immune Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Immune Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Immune Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Immune Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Immune Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Immune Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Immune Drugs Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Immune Drugs Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Immune Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Immune Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Immune Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Immune Drugs Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Immune Drugs Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Immune Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Immune Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Immune Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Immune Drugs by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Immune Drugs by Type (2020-2031)
 Figure 54. Global Immune Drugs Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Immune Drugs by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Immune Drugs by Application (2020-2031)
 Figure 57. Global Immune Drugs Price (US$/Unit) by Application (2020-2031)
 Figure 58. Immune Drugs Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Next Generation Immunology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Autoimmune Diseases Treatment Market Research Report 2024
Autoimmune Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vaccine Digital Data Logger Market Insights Forecast to 2030
Global Diagnostic Guidewire Market Research Report 2024
Global Next Generation Antibody Drug Market Research Report 2024
Super Generic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Generic Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Still s Disease Treatment Market Research Report 2025
Influenza Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti Infectives Market Research Report 2025
Systemic Infection Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Immune System Allergy Treatment Market Research Report 2025
Global Pharmerging Market Research Report 2025
Global CGT Drugs Market Research Report 2025
Global Asthma Therapeutics Market Research Report 2025
Cancers Immunotherapy Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Prescription Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Drug Safety and Pharmacovigilance Service Market Research Report 2025
Global Ant Killer Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions